More hospitals dossis blood clot removal system:
This article was originally published in Clinica
Executive Summary
The FDA has allowed three more hospitals to take part in clinical trials of Possis Medical's AngioJet rapid thrombectomy system. The study involves the treatment of ten carotid stroke patients using the US company's blood clot removal system. The device is is indicated for treating all blood vessels of any size throughout the body.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.